Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/imj.14889 http://scihub22266oqcxt.onion/10.1111/imj.14889 32656985!7405147!32656985     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32656985&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Intern+Med+J 2020 ; 50 (7): 798-804 Nephropedia Template TP {{tp|p=32656985|t=2020. Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty |pdf=|usr=}}{{32656985}} gab.com Text Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty JO: Intern Med J http://www.kidney.de/pget.php?&tw=1&pmid=32656985 #FOAvip The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has emerged as a public health emergency and challenged healthcare systems globally. In a minority of patients, SARS-CoV-2 manifests with a severe acute respiratory illness and currently there is insufficient data regarding the virulence of COVID-19 in inflammatory bowel disease patients taking immunosuppressive therapy. This review aims to summarise the current literature and provide guidance on the management of inflammatory bowel disease patients in the context of the COVID-19 pandemic in the Australasian setting. Twit Text FOAVip Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty ????Intern Med J http://www.kidney.de/pget.php?&tw=1&pmid=32656985 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32656985 #FOAvip English Wikipedia <ref>{{Cite pmid|32656985}}</ref> Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty #MMPMID32656985 Aysha AA; Rentsch C; Prentice R; Johnson D; Bryant RV; Ward MG; Costello SP; Lewindon P; Ghaly S; Connor SJ; Begun J; Christensen B Intern Med J 2020[Jul]; 50 (7): 798-804 PMID32656985show ga The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has emerged as a public health emergency and challenged healthcare systems globally. In a minority of patients, SARS-CoV-2 manifests with a severe acute respiratory illness and currently there is insufficient data regarding the virulence of COVID-19 in inflammatory bowel disease patients taking immunosuppressive therapy. This review aims to summarise the current literature and provide guidance on the management of inflammatory bowel disease patients in the context of the COVID-19 pandemic in the Australasian setting. |*Coronavirus Infections/epidemiology/prevention & control[MESH] |*Gastroenterology/organization & administration/trends[MESH] |*Inflammatory Bowel Diseases/epidemiology/immunology/therapy[MESH] |*Pandemics/prevention & control[MESH] |*Patient Care Management/methods/trends[MESH] |*Pneumonia, Viral/epidemiology/prevention & control[MESH] |Australia[MESH] |Betacoronavirus/isolation & purification[MESH] |COVID-19[MESH] |Change Management[MESH] |Disease Management[MESH] |Humans[MESH] |Immunologic Factors/*pharmacology[MESH] |Practice Guidelines as Topic[MESH] |Risk Management[MESH]Practical management of inflammatory bowel disease patients during the(epmc).pdf DeepDyve Pubget Overpricing